Skip to main content
. 2021 Apr 8;22(8):3867. doi: 10.3390/ijms22083867

Figure 1.

Figure 1

Major classes of immunotherapeutic approaches to harness patient’s immune response against tumor cells in glioblastomas (GBMs).